Hideyuki Okano, M.D., Ph.D., Founding Scientist
Dean of Keio Medical School
Professor, Department of Physiology at Keio University School of Medicine. Dr. Okano is a world-recognized expert in regulatory mechanisms of neuronal development and stem cell biology.
George R. Martin, Ph.D
Former Scientific Director, National Institute on Aging (NIH) and Senior VP. Fibrogen. Dr.Martin is a world-recognized leader in biochemical research and product development.
Arnold Caplan, Ph.D
Professor of Biology, Professor of General Medical Sciences, and Director of the Cellular and Molecular Basis for Aging Training Program at Case Western Reserve University. Dr. Caplan is a pioneer in research on mesenchymal stem cells. His research focuses on understanding the development, maturation and aging of cartilage, bone, skin and other mesenchymal tissues.
Martha C. Bohn, Ph.D
Medical Research Institute Council Professor and Director of the Neurobiology Program, Children's Memorial Research Center, Northwestern University. Dr. Bohn's research concentrates on gene delivery and cellular therapy mechanisms to increase expression of neurotrophic factors and genes that interfere with neuronal cell death in Parkinson's disease.
Cesar V. Borlongan, Ph.D
Professor at University of South Florida. Pioneer in translational research on cellular therapy for stroke and traumalic brain injury.
Krys Bankiewicz, M.D., Ph.D
Professor, Neurological Surgery, University of California, San Francisco. Dr. Bankiewicz directs translational research at the Brain Tumor Research Center and the Movement Disorders Research Program at the University of California, San Francisco, focusing on drug delivery and gene transfer therapies in models of Parkinson's disease and brain tumors.
Yoichi Nabeshima, MD, Ph.D
Professor, Department of Pathology and Tumor Biology, Kyoto University Graduate School of Medicine. Dr. Nabeshima directs a laboratory studying the molecular mechanisms of aging and cell differentiation.